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Abstract: 
 
A miniaturized, localized surface plasmon resonance (LSPR)-coupled fiber-optic (FO) 
nanoprobe is reported as a biosensor that is capable of label-free, sensitive detection of a cancer 
protein biomarker, free prostate specific antigen (f-PSA). The biosensor is based on the LSPR at 
the reusable dielectric-metallic hybrid interface with a robust, gold nano-disk array at the fiber 
end facet that is directly fabricated using EBL and metal lift-off process. The f-PSA has been 
detected with a mouse anti-human PSA monoclonal antibody (mAb) as a specific receptor linked 
with a self-assembled monolayer at the LSPR-FO facet surfaces. Experimental investigation and 
data analysis found near field refractive index (RI) sensitivity at ~226 nm/RIU with current 
LSPR-FO nanoprobe, and demonstrated the lowest limit of detection (LOD) at 100 fg/mL 
(~3 fM) of f-PSA in PBS solutions. The control experimentation using 5 mg/mL bovine serum 
albumin in PBS and nonspecific surface test shows the excellent specificity and selectivity in the 
detection of f-PSA in PBS. These results present important progress towards a miniaturized, 
multifunctional fiber-optic technology that integrates informational communication and sensing 
function for developing a high performance, label-free, point-of-care (POC) device. 
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Article: 
 
1. Introduction 
 
Fiber-optic (FO) technology has been well-developed for optical communication (Palais, 2004); 
and the FO-based sensing technology has been existing as a powerful, analytical tool for a wide 
spectrum of applications (Wang and Wolfbeis, 2012, Wolfbeis, 2006, Wolfbeis, 2008), ranging 
from gas (Aernecke and Walt, 2009), chemical (Smythe et al., 2009), and biomolecule (Tam et 
al., 2009) detection. In recent years, FO technology has continued to enhance healthcare 
capability by providing effective and convenient lab tools in biomedical applications (Ben-David 
and Gannot, 2007, Utzinger and Richards-Kortum, 2003), such as medical diagnostics (Bluestein 
et al., 1990) and therapeutics (Yoo et al., 2013), and in particular for use at inaccessible sites 
or remote monitoring. More recently, an emerging lab-on-fiber concept (Consales et al., 
2012a, Consales et al., 2012b) is proposed to develop a new generation of miniaturized “lab” 
platform at optical fiber tip for both communication and sensing applications. In particular, the 
advances of surface plasmon resonance (SPR)-enhanced, refractive index (RI) sensing schemed, 
spectroscopic FO probe technology (Chang et al., 2012, Jeong et al., 2013, Lin et al., 
2011a, Shevchenko et al., 2011) have demonstrated the ability for label-free bio-detection. 
 
Surface plasmons (Raether, 1988) (SPs) are very sensitive to the near surface refractive index 
(RI) changes and well-suited to the detection of surface binding events. They have been 
exploited extensively in a variety of SPR-based sensors and biosensors (Homola, 2008). 
Particularly, the LSPR, caused by resonant SPs localized in nanosystems, has applications in 
detection of chemical and biological agents with single molecule sensitivity (Mayer and Hafner, 
2011, Stewart et al., 2008, Valsecchi and Brolo, 2013). To date, various tailored noble 
metal nanoparticles (Bingham et al., 2009, Juvé et al., 2013, Lyon et al., 1998), nanograting 
metal film structures, such as nanoholes (Brolo et al., 2004, Im et al., 2009, Im et al., 
2012, Sharpe et al., 2008), nanorings (Kim et al., 2006, Larsson et al., 2007, Liu et al., 2011), 
nanoslits (Jung et al., 2006, Lee et al., 2008, Wei et al., 2010), have been successfully fabricated 
for LSPR sensor applications. Modulation of the nano-structures array’s optical responses by 
adsorbed analytes is expected to offer improved sensitivity and selectivity over conventional 
SPR methods. 
 
The implementation of a LSPR-FO-based sensor by integrating the LSPR nanoprobe to 
communicative fiber optics may offer many advantages, especially in terms of avoiding the use 
of bulky optics and high-precision mechanics for angular or wavelength interrogation of metal 
films in contact with analytes (Mullett et al., 2000, Shevchenko et al., 2011, Wang and Wolfbeis, 
2012). In order to achieve the LSPR structure at the fiber end facet, a few approaches have been 
pursued in the past, and progresses have been made, including random immobilization of Au or 
Ag nanoparticles (NPs) (Chang et al., 2012, Jeong et al., 2013, Mitsui et al., 2004), 
controllable fabrication of Au nanostructures, e.g. focus ion beam (FIB) milling (Dhawan et al., 
2008), or a nanoskiving method (Lipomi et al., 2010), etc. Nevertheless, there is a need to 
develop advanced LSPR-FO biosensors that may provide high performance, e.g. enhanced 
stability and high RI sensitivity, and overcome unwanted doping (Fu and Bryan, 2005), or weak 
adhesion (Dhawan et al., 2008). 
 
For many years, cancer has been diagnosed and treated after the cancer cells have already 
invaded surrounding tissues and metastasized throughout the body, resulting in low survival 
rates. Early detection is the key to cancer survival, particularly so for cancers of prostate, breast, 
cervix, mouth, larynx, colon/rectum, and skin. Biomarkers of cancers have been found to be very 
important tools for cancer detection and monitoring, because they serve as hallmarks for the 
physiological status of a cell at a given time and change during the disease process. A few 
technologies have been used in biomarker applications (Wulfkuhle et al., 2003), especially in the 
fields of genomics and proteomics for biomarker discovery and early detection, such as DNA 
arrays and DNA sequencing methods, enzyme-linked immunosorbent assays (ELISAs), two-
dimensional polyacrylamide gel electrophoresis, mass spectrometry, proteomic pattern 
diagnostics, and protein arrays. Recent advances of biomarker detection have been made in 
optical (fluorescence (Mukundan et al., 2009), light scattering (Liu et al., 2008), SERS (Sekhar et 
al., 2008), electrochemical (Mani et al., 2009, Ramgir et al., 2007, Tang et al., 2008, Yu et al., 
2006), functional quartz crystal microbalance (Henne et al., 2006), microcantilevers (Baker et al., 
2008) and surface plasmon resonance (SPR) (Hegnerová et al., 2009, Kumar et al., 2007, Lee et 
al., 2006) sensors. Harnessing the advances in biological ligand interactions, the fiber-optic 
technology incorporating LSPR-nanoprobe sensing may provide an alternative tool for effective 
biomarker diagnosis via a compact, label-free format that does not require a dedicated laboratory 
facility or highly trained personnel. 
 
In this paper, we report on the progress of developing a miniaturized LSPR-FO probe and 
demonstration of sensitive, label-free detection of a protein cancer biomarker, free prostate-
specific antigen (f-PSA). First, a low-cost lift-off process was adapted to fabricate 
gold nanodisk arrays at the end of tip-facet, providing a very stable, robust and clean LSPR 
fiber tip probe. Then, the probe was functionalized via a facile self-assembled monolayer (SAM) 
of alkanethiolates on the gold nanodisk array to attach a capture ligand, anti-PSA antibody, as a 
selective immunoassay for detection of the f-PSA. The reported label-free LSPR fiber biosensor 
may allow an alternative approach for direct discrimination of the cancer biomarkers, and 
potentially developing a miniaturized, point-of-care (POC) device for early disease diagnosis. 
 
2. Materials and methods 
 
2.1. Materials and reagents 
 
11-MecaptoundecanoFeic acid (HSC10COOH, 99%), 8-Mercapto-1-Octanol (HSC8OH, 
98%), N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), N-
hydroxysuccinimide (NHS), and glycine were purchased from Sigma-Aldrich (Milwaukee, WI) 
and used without further purification. Mouse anti-human PSA monoclonal antibody (capture 
mAb), human free-PSA (Cat.# 10050) and ELISA kits for CA125 were obtained from Anogen-
YES Biotech Laboratories Ltd. (Mississauga, Canada). The 5 ng/mL free-PSA standard solution 
was used for preparation of free-PSA solutions with lower concentrations obtained using sample 
dilutant provided in the ELISA kit. The 5 ng/mL free-PSA standard solution was prepared in 
a protein matrix solution according to the World Health Organization (WHO) standard by the 
vendor. All solvents and other chemicals were purchased from Sigma and used without further 
purification. Single-mode optical fiber for 633 nm wavelength was purchased from Newport 
Corporation (F-SV). 
 
2.2. Fabrication of LSPR-FO nanoprobe 
 
In this study, a lift-off process was developed to transfer patterns at nanometer sizes, which 
offers advantages of minimum damage to the fiber end facet, and without expensive plasma etch 
step. A single-mode optical fiber for 633 nm wavelength, which has a 4.3 µm mode field 
diameter, a 125 µm cladding diameter and a 245 µm polymer buffer coating diameter, was used 
in the fabrication. The advantage of using this small core fiber is that it provides great spectral 
stability in the wavelength ranges of 600 nm to 750 nm, in which the resonance peaks of 
fabricated fiber tip LSPR sensors were typically located. The preparation of optical fiber end 
facet includes stripping off the polymer buffer layer 4 cm from the end. The end face of the 
optical fiber was cleaved perpendicular to the fiber axis using an optical fiber cleaver. The fiber 
end facet was cleaned with acetone and isopropyl alcohol rinse, followed by 120 °C oven bake 
for 10 min. 2 nm of Cr was deposited on the fiber end face using vacuum sputtering method 
(Denton sputtering system) to provide a conductive layer for the EBL process, and also as 
an adhesive layer for Au film overlay in the later step. 
 
The fabrication process of LSPR-FO probe can be divided into two steps. In the first step, nano-
pattern was created on the fiber end face using EBL. We used a simple and unique e-beam resist 
coating method “dip and vibration” technique developed in our previous study to deposit 
~150 nm e-beam resist (ZEP520A, Zeon Chemicals, Japan) on the fiber end facet (Lin et al., 
2009, Lin et al., 2011b, Lin et al., 2010). Then an EBL based on the Nano Pattern Generation 
System (NPGS) and a field emission scanning electron microscope (FESEM) were used to 
create nanodisks array pattern on the e-beam resist on the fiber end facet. A customized fiber 
holder was used to hold the fiber vertically on the translational stage in the SEM chamber. The 
EBL voltage was set at 20 kV and the exposure dose was 70 μC/cm2. After EBL process, the 
fiber tip was developed by dipping in resist developer (ZEP N50) for 1 min. The fiber tip was 
then rinsed in DI water and baked in the 120 °C oven for dehydration. 
 
In the second step, the nano-pattern was transferred to the Au layer using a metal lift-off method. 
The deposition of 40 nm Au overlay over the nano-patterned fiber end facet was carried out by 
using standard thermal evaporation coating technique. The 2 nm Cr layer previously deposited as 
conductive layer for EBL process is now served as an adhesive layer for Au overlay. To lift-off 
the e-beam resist, the fiber tip was dipped in the ZEP remover for 10 min, followed by a 1-min 
ultrasonic bath to assist the lift-off process. The fiber tip was then rinsed in DI water and dried in 
the nitrogen stream. An optical microscope with 100× objective lens was used to check the fiber 
end facet to make sure that the resist layer has been completely removed. If the lift-off process 
was not completed, ZEP remover and ultrasonic bath may be used to further remove the e-beam 
resist. After the lift-off process, the fiber tip was cleaned by DI water rinse and dry in N2 stream. 
Then the fiber tip was dipped into the Cr remover solution for 30 s to remove the Cr layer that 
was not covered by the Au nanodisks. The fiber tip was rinsed in DI water and baked in the 
120 °C oven for dehydration. Finally the Au nanodisk array on fiber end face was annealed at 
530 °C for 5 min and ready for next usage. 
 
2.3. Optical measurement 
 
In this optical setup (Fig. 1), a 2×1 single mode optical fiber coupler for 633 nm wavelength is 
used, which has three light connection ports. In Fig. 1, port (a) and port (b) are two connections 
on one side of optical fiber coupler, and port (c) is connection on the opposite side. Port (a) is 
connected to a tungsten halogen white light source (LS-1, Ocean Optics Inc., USA.); port (b) is 
connected to a mini-spectrometer (Ocean Optics USB2000); and port (c) is connected to the 
LSPR-FO probe using a fusion splicer. The white light (450–950 nm) is launched from port (a), 
propagated to port (c), and reflected from the end facet with the Au nanodisks arrays. The 
reflection light propagated to port (b), where the spectrum of the reflection light is measured by 
the mini-spectrometer, which is connected to a computer for data acquisition and processing. 
 
 
Fig. 1. Optical setup for the fiber tip LSPR sensor based on reflection spectrum measurement. 
 
Before starting the experiment, the sensor tip must be cleaned of any impurities or other 
contaminants. The sensor tip is rinsed with ethanol to clean the tip. A baseline wavelength is 
achieved if the sensor tip returns to this wavelength three times after being washed in deionized 
water. If the tip spectra do not return to this line, acetone and isopropyl alcohol may be used to 
further clean the tip of lingering impurities. 
 
In order to get the LSPR spectrum response due to Au nanostructures on the fiber end facet, a 
reference spectrum and a dark spectrum need to be recorded. The reference spectrum was 
acquired with no fiber LSPR probe on port (c), and the fiber end face of port (c) was 
perpendicularly cleaved. The dark spectrum was obtained by turning off both the tungsten 
halogen light source and room light. The measured reflection spectra (Mλ) of the fiber tip sensor 
probe was obtained by the equation: 
 
𝑀𝑀𝜆𝜆 = (𝑆𝑆𝜆𝜆 − 𝐷𝐷𝜆𝜆) (𝑅𝑅𝜆𝜆 − 𝐷𝐷𝜆𝜆)⁄ × 100% (1) 
 
In Eq. (1), Sλ is the sample intensity, Dλ is the dark intensity, and Rλ is the reference intensity at 
wavelength λ. 
 
2.4. Functionalization of the LSPR-FO nanoprobe 
 
The immobilization of mAb at the LSPR-FO sensor surface is similar to a procedure previously 
reported (Zhang et al., 2012). Briefly, the cleaned fiber tip was first incubated in a mixture of 
1 mM HSC10COOH and HSC8OH with mole ratio 1:5 in absolute ethanol solution for 1 h. 
The self-assembled monolayer (SAM) tethered with carboxylic acid groups then was activated 
by incubation in a pH 7.0, 10 mM phosphate buffer solution containing 0.5 mM of EDC/NHS, 
respectively for 1 h. The activated SAM was rinsed with the distilled water and immediately 
moved to a freshly prepared 10 mM PBS containing 10 µg/mL of the detector mAb for 1 h 
incubation. The fiber probe was rinsed with the PBS and followed by dipping in a 0.2 M 
glycine PBS solution for 10 min in order to deactivate the remaining active sites at the SAM. The 
LSPR-FO sensor was ready for free-PSA binding detection. 
 
2.5. Detection of f-PSA biomarker 
 
Once the antibodies (mAbs) have been immobilized on the gold nanodisks fiber tip surface, the 
LSPR-FO sensor is ready for detection of f-PSA. During the experiments, PBS (containing 
0.05% tween-20) was used as a running buffer to help minimizing the nonspecific adsorption of 
the f-PSA at the fiber tips. In order to test binding of PSA to the anti-PSA mAb modified 
surfaces, five tenfold dilutions of a 5 ng/mL concentration of f-PSA were prepared in PBS 
solution for the desired concentrations. The sensor tip was placed in the f-PSA PBS for 10 min in 
the sequence from the lowest concentration of 50 fg/mL to measure the reflectance spectrum. 
After each measurement, the fiber tip was rinsed thoroughly with DI water, and dry in the air. All 
spectra were obtained after fiber tip was cleaned and dried in the air. Control experiments have 
been designed and carried out to evaluate the specificity/selectivity of the immunoassay using 
the LSPR-FO devices. Specifically, the binding between the detector mAb and bovine serum 
albumin (BSA) at concentrations of 5 mg/mL has been evaluated. We select BSA for this 
preliminary study, because the BSA is similar to human serum albumin. Additionally, in order to 
evaluate the nonspecific binding to the SAM, we tested the LSPR-FO devices modified only 
with the mix SAM of HSC10COOH and HSC8OH SAM without antibody attached by following 
the f-PSA detection process. 
 
3. Results and discussion 
 
3.1. Fabrication results and characterization 
 
SEM images of a typical fabricated LSPR-FO probe are shown in Fig. 2. Fig. 2a shows the end 
face of the optical fiber with nine patches of nanodisk arrays. Each patch has a size of 30 µm by 
30 µm, includes 75×75 Au nanodisk array with 400 nm pitch. Although nine patches are 
constructed on the fiber end face, only the center one will be involved in biosensing, since 
the excitation light is highly confined in the fiber core, which has a diameter around 4 µm 
located at the center of the cladding. The other patches are there for monitoring the e-beam dose 
in the EBL process, and will not interference with the biosensing process in anyway. Fig. 2b 
shows the close up SEM image of Au nanodisks right after the lift-off process. The Au nanodisks 
appear to be circular with some edge roughness, 167.5 nm in diameter. Fig. 2c shows close up 
SEM image of the Au nanodisk array after annealing at 530 °C for 5 min. The diameter of Au 
nanodisks reduced to 156.3 nm with significantly less edge roughness. 
 
 
Fig. 2. Scanning electron micrographs of a gold nanodisks array on an optical fiber end facet. (a) 
Overview of the optical fiber end facet, (b) gold nanodisks array on the optical fiber facet after 
the lift-off process, and (c) gold nanodisks array on the optical fiber facet after annealing. 
 
3.2. Nanoprobe sensitivity 
 
The solvents used in determining the bulk RI sensitivity of the LSPR tip were acetone, methanol, 
ethanol, isopropyl alcohol, and water of different RIs. The sensitivity is used to determine if the 
sensor tip in experimentation would be perceptive enough to determine if small wavelength 
shifts accurately. The LSPR-FO nanoprobe was dipped in the various solvents, and the spectra of 
the reflected light were recorded respectively, as shown in Fig. 3a. Please note that there is a 
noisy region in all spectra from ~760 nm to 800 nm, which is caused by the transmission 
minimum for the optical fiber coupler (single mode at 633 nm) in the same wavelength range. To 
determine the peak wavelength in the LSPR reflection spectrum, a Matlab program was created 
to fit the data to an eighth order polynomial function over a range of 80 nm, centered at the 
wavelength of maximum reflection in the raw data. The calculated LSPR wavelength red shifted 
as the RI of the solvent increased. A linear relationship between the LSPR peak wavelength and 
the bulk RI of the medium was obtained (Fig. 3b), with the sensitivity of 226 nm/RIU used in 
this study. We also investigated the light intensity based RI sensitivity. The return light 
intensities at the LSPR peak wavelength were plotted against the bulk RI of the media. The 
LSPR peak intensity is seen to be linearly proportional to the RI, and the gradient of the line is 
123 per RIU. The return light intensity of a single wavelength laser can be used as a probing 
light for the refractive index change due to biochemistry binding events, thus eliminate the need 
for a broadband light source and optical spectrometer for a LSPR biosensing, which is underway. 
In this work, the spectral peak shifts using a white incident light were obtained for the 
experimentation data analysis. 
 
 
Fig. 3. (a) Measured reflection spectra for the LSPR-FO probe in various solvents. (b) Linear fit 
of the LSPR peak wavelengths (left axis) and LSPR peak intensity (right axis) with the index of 
refraction of the solvents.  
 
3.3. Functionalization of the LSPR-FO nanoprobe 
 
The SAM preparation from thiolated molecules at gold surfaces is well-established by the thiol-
gold bond interactions (Wei et al., 2002). The SAM tethered with carboxylic acid groups is easy 
to be activated for biological molecule immobilization. A previously developed protocol (Zhang 
et al., 2012) was used to effectively immobilize the capture mAbs. With this method, the capture 
mAbs of f-PSA are covalently immobilized to the fiber tip facet via the monolayer and they are 
accessible for protein conjugation while maintaining native protein structure. After the antibody 
(mAb) attachment, the monolayer is deactivated by glycine to avoid non-specific adhesion to the 
active intermediates. Finally, the fiber probe was rinsed thoroughly with PBS and DI water. In 
such a way, the mAbs are tethered to the fiber Au nanodisks array tip surface and ready for f-
PSA binding detection. 
 
To ensure consistency in the surface functionalization with SAM and antibody attachment, the 
internal reflectance spectra of the Au nanodisks array FO tip interface were measured after 
each functionalization step. Because the thickness changes of the organic film at the LSPR 
surfaces will cause the effective RI changes near the surface; consequently, each step of 
modification at the LSPR probe surface can be detected optically by observing the LSPR 
wavelength shift (Jung et al., 1998). Fig. 4 shows the typical reflectance spectra of each step 
during the surface functionalization. The inserted image shows the smoothed spectra at the peak 
region by the Matlab program and the reflectance intensity is normalized to maximum peak 
intensity of each spectrum. The real-time monitoring of four individual LSPR-FO tips was 
performed, and consistent responses were obtained. In Fig. 4, one can see clear red shift after 
each step modification of the Au nanodisk array surface from the -SC11COOH/SC8OH SAM 
formation to mAb immobilization. The spectrum of the last step of glycine deactivation is almost 
duplicated to the step of mAb immobilization (a tiny blue shift within the spectrometer resolution 
0.4 nm). This is expected because the effective RI changes depend on the amount of molecules 
attached to the nanostructures (Jung et al., 2006). The step-wise peak shift is originated from the 
near field plasmon resonance and interaction when the molecules of different dielectric constant 
attached to the nanostructured interface (Haes and Duyne, 2004, Haes et al., 2006, Yonzon et al., 
2004). 
 
 
Fig. 4. Real-time reflectance spectra of the each step during the surface functionalization. Insert: 
spectra normalized to peak intensity to show the LSPR reflectance wavelength shifts.  
 
Additional details of the surface modification were analyzed according to the LSPR spectral 
peak shift. By assuming that the total change comes from increasing the organic layer thickness, 
the effective dielectric constant at the modified interface can be calculated according to reference 
(Jung et al., 1998). From the above measured bulk RI sensitivity of 226 nm/RIU, one is able to 
estimate the equivalent molecular thickness of each step modification added to the precedent step 
according to the equation (Haemers et al., 2002, Jung et al., 1998): 
 
Δ𝑅𝑅 = 𝑚𝑚(𝑛𝑛𝑎𝑎𝑎𝑎𝑎𝑎 − 𝑛𝑛𝑎𝑎𝑎𝑎𝑎𝑎)�exp�−2𝑑𝑑𝑝𝑝𝑎𝑎𝑝𝑝 𝑙𝑙𝑎𝑎⁄ ���1− exp�−2𝑑𝑑𝑝𝑝𝑎𝑎𝑝𝑝 𝑙𝑙𝑎𝑎⁄ �� (2) 
 
In Eq. (2), ΔR is defined as the SPR signal response (peak shift or intensity change) after the 
addition of molecule layer to the precedent step modification, and m is obtained from the slope 
of the calibration plot (i.e. the RIU sensitivity). dpre is the effective thickness of the existing layer 
(using 0.8 nm for the first SAM layer), ld is the decay length of SP mode into the dielectric at the 
nanodisk array (two ld value of 30 and 45 nm were used respectively for calculation according to 
the nanodisk dimension aspect (Chen et al., 2009)), and refractive indices of organic molecules is 
taken to be 1.5 (nadd) and that of air is 1.0 (nair). According to our measured average ΔR, the 
calculated equivalent thickness increases of individual steps are presented in Table 1S. The 
increases in the layer thickness at the nanodisk tip interface are found to be ~0.5 nm (ld 30 nm), 
or 0.73 nm (ld 45 nm) for O-acylisourea intermediates after EDC/NHS, and 1.73 nm (ld 30 nm) 
or 2.55 nm (ld 45 nm) for mAb immobilization. Assuming that all of this increase comes 
from molecular adsorption, taking the mass weight of the mAb to be 29 kDa, and using a 
globular diameter of 2.6 nm (Erickson, 2009), the coverage of mAb at the LSPR sensing area is 
estimated to be ~67% (ld 30 nm) or ~98% (ld 45 nm). 
 
The monitoring of the LSPR spectral peak shift is important to verify the success of LSPR tip 
functionalization with SAM and mAb. The measurement has in-situ convenience and is very 
effective since there is no need of any optical tag or label process. In addition, this procedure 
assures the complete rinse off the non-covalently bounded molecules, which is an important step 
to warranty the consistent measurements from individual fiber tip fabricated separately. 
Moreover, the quantitative analysis of surface functionalization, e.g. mAb coverage as function 
of RI sensitivity, is particular useful for prediction of bio-detection, and estimate of the amount 
of mAb immobilization at the LSPR-FO sensor area and prediction of its capability (LOD) of the 
target biomolecules. It will be very helpful to guide future development of reliable and 
reproducible bundled LSPR-FO arrays for multiplexed biomarker screening. 
 
3.4. Cancer biomarker f-PSA detection 
 
For demonstration, we select the FDA approved prostate cancer protein, PSA, as a model 
biomarker for this study. f-PSA is normally present in the blood at very low levels. The upper 
limit of normal concentration is much less than 4 ng/mL (Thompson et al., 2004). Hence, various 
concentrations of f-PSA from 50 fg/mL to 5 ng/mL in PBS solutions were used to demonstrate 
the capability of protein biomarker detection by the mAb functionalized LSPR-FO nanoprobe. 
For each concentration, the reaction time was 10 min (longer reaction time, e.g. 1–2 h, just 
generates insignificant further red shift, which means a dynamic equilibrium status has reached); 
and then the tip was rinsed in water and dried in nitrogen stream. Thereafter, the reflection 
spectrum was recorded in air until stable (see Fig. S1). After the set of measurements, the 
monolayer film was completely removed from the fiber tip by immersing it in a “piranha” 
solution (a mixture of 30% H2O2 and 98% H2SO4 in a 1:3 volume ratio) for 60 s, and then rinsed 
by water and ethanol. Typically a fiber tip probe can be reused for ~10 full functionalization and 
detection cycles. It proved that the fabricated nanodisk array at the tip facet is very stable and 
reusable. 
 
Fig. 5 shows the representative reflectance spectra of f-PSA detection sensing various f-PSA 
concentrations from 0 ng/mL to 5 ng/mL. As expected, the primary resonance peak red shifts 
when the nanodisk array is exposed to f-PSA, and the red shift increases with increasing f-PSA 
concentration (Jung et al., 1998, Jung et al., 2006). The smoothed curve (the inserted in Fig. 
5 and spectra are normalized to peak intensity) was used to determine the peak position and the 
value of peak shifts at different f-PSA concentrations. 
 
 
Fig. 5. The reflectance spectra of the anti-PSA mAb modified LSPR-FO tip in various of f-PSA 
concentration solutions. Insert: spectra are normalized to peak intensity to show 
the LSPR reflectance wavelength shifts.  
 
 
Fig. 6. Correlation of f-PSA concentration to the reflectance light of resonance peak wavelength.  
 
3.5. Resonance peak shift 
 
Fig. 6 shows the dependence of the wavelength peak shift on the f-PSA concentration. The peak 
shift for each point was obtained by averaging three measurements. The linear fit of the peak 
shift with logarithmic value of the f-PSA concentration gives R2 value of 0.977 (corresponding 
concentration ranging 50 fg/mL to 5 ng/mL) and 0.997 (corresponding concentration ranging 
500 fg/mL to 5 ng/mL), respectively, suggesting a more reliable concentration determination for 
the range of 500 fg/mL to 5 ng/mL. The LOD is described as the lowest concentration for clear 
identification of wavelength shift. The largest standard deviation of the experimental data for 3 
tests is around ±0.6 nm. A wavelength shift of twice of the largest standard deviation (1.2 nm) 
can be used to determine LOD of the fiber LSPR sensors, which corresponds to 100 fg/ml of f-
PSA in PBS solution. To our best knowledge, this is one of the most sensitive LSPR-
FO biosensors reported in the literatures (Jeong et al., 2013). 
 
Using the peak shift ~11.8 nm (against to mAb tip) after exposed to 5 ng/mL f-PSA and Eq. (2), 
the calculated total thickness increase is 1.97 nm (with ld 30 nm) or 2.9 nm (with ld 45 nm), 
corresponding coverage of 61% or 90%, respectively (using mass weight 34 kDa and size of 
3.2 nm as globular diameter), lower than the coverage of mAb, respectively. This suggests the 
5 ng/mL yet not reach the highest concentration limit of detection for current LSPR-FO 
biosensor. Based on the coverage of mAb (~67% with ld 30 nm or ~98% with ld 45 nm) and 
assuming fully binding to f-PSA, the calculated peak shift will be 12.85 nm (with ld 30 nm) or 
12.61 nm (with ld 40 nm) referred to mAb layer, obtaining the predicted highest concentration of 
f-PSA LOD to be 15.7 ng/mL (ld 30 nm) or 12.5 ng/mL (ld 40 nm) by fitting to Fig. 6. We 
conclude that the effective LOD of current LSPR-FO biosensor is expected to be ranging from 
100 fg/mL (~3 fM) to 15 ng/mL (~0.5 nM). 
 
As a comparison, the analysis using the reflectance peak intensity is described in supplemental 
information (Fig. S2). The linear fit of the intensity with logarithmic value of the f-PSA 
concentration gives an R2 value of 0.992 corresponding to concentration ranges of 50 fg/mL to 
5 ng/mL, and 0.95 corresponding to concentration ranges of 50 fg/mL to 5 ng/mL, similar to the 
observation of the peak wavelength signal transduction. The data analysis by following the above 
described process on peak shift gives the same conclusion. 
 
3.6. Control experimentation 
 
Control experiments were performed to verify the specificity of mAb to f-PSA using a 
concentration (5 mg/mL) of BSA in PBS with the mAb LSPR-FO sensor. The peak shift of 
LSPR-FO with mAb in the concentration (5 mg/mL) of BSA gives ±0.6 nm from three trials, 
indicating little nonspecific binding BSA to the mAb modified fiber tip. In a previous study 
(Zhang et al., 2012), the binding between an mAb modified Au nanostructure to rabbit IgG has 
been performed, which indicates excellent specificity/selectivity of the immunoassay to f-PSA. 
In addition, the non-specific binding of the f-PSA has been performed using the mix SAM of 
HSC10COOH and HSC8OH SAM (1:5) modified LSPR-FO tip in the various f-PSA 
concentrations. From the original reflectance spectra obtained in the f-PSA solutions (Fig. S3), 
one can see insignificant changes on both the peak wavelength and the light intensity with the 
range of 0–5 ng/mL f-PSA. Three sets of individually prepared tip were measured and the 
average peak shift is shown in Fig. 6 (blue diamond symbol, see raw data in Table S2). The 
maximum shift is about 1 nm. Since a reference of SAM-mAb modified tip was collected as the 
baseline for data analysis, the measured results of the f-PSA detection are consistent and 
effective for the bioassay. The non-specific binding of f-PSA is not an issue for the LSPR-FO 
biosensor. These results indicate that the nanodisk array based LSPR-FO devices, along with 
tailored surface modification with appropriate receptors, can be used as cancer biomarker 
detection with excellent sensitivity and specificity at the tested concentration range. Preliminary 
unpublished results for f-PSA detection in human serum have shown the promise to apply the 
LSPR-FO biosensor on clinical sample analysis for health care monitoring. 
 
4. Conclusion 
 
In summary, a multifunctional fiber-optic device that holds robust gold nanodisk arrays at the 
end of fiber tip facet has been investigated as a miniaturized, ultrasensitive LSPR-
FO biosensor by using the internal reflectance spectrum. The Au nanodisk array probe can be 
cleaned and resused for surface functionalization. A consistent red shift of the 
primary LSPR peak was observed as the RI increases near the tip surface, validating this 
nanoplasmonics-based fiber-optic probe for quantitative detection of binding analyte. The bulky 
RI sensitivity of the LSPR-FO nanoprobe is measured as ~226 nm/RIU which is comparable 
to gold nanoparticle array-based LSPR sensors on planar substrate. The chemical 
and biochemical functionalization of the nanostructured tip surfaces is monitored in real-time by 
measuring the LSPR reflection with an incident white light at the FO tip facet interfaces. The 
LSPR-FO biosensor functionalized with mAb demonstrates an ultrasensitive detection of f-PSA 
with LOD range of 100 fg/mL (~3 fM) to 5 ng/mL (~0.15 nM) in PBS. Control experimental 
investigations indicate the high specificity and selectivity of the immunoassay used in the 
sensing of f-PSA. Moreover, the lift-off resist procedure is adaptable for fabrication of the 
nanodisk arrays at bundled fiber tip facets; hence it is of great potential to prepare a number of 
miniaturized, structurally stable multi-functional LSPR-FO biosensors for label-free, highly 
multiplexed sensing applications, progressing towards to develop a novel generation of lab-on-
fiber point-of-care (POC) device for early diagnosis/prognosis of cancers and other diseases in 
health care sectors. 
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